Article Sidebar
Published:
May 16, 2023Keywords:
Article Details
Open access articles published in the Journal of Agriculture, Science and Technology are under the terms of the Creative Commons Attribution (CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited. The CC BY license permits commercial and non-commercial re-use of an open-access article, as long as the author is properly attributed.
Copyright on any research article published in the Journal of Agriculture, Science and Technology is retained by the author(s). The authors grant the Journal of Agriculture, Science and Technology with a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its original authors, citation details and publisher are identified.
Use of the article in whole or in part in any medium requires proper citation as follows:
Title of Article, Names of the Author, Year of Publication, Journal Title, Volume (Issue) and page. Links to the final article on the JSRE website are encouraged.
The Creative Commons Attribution License does not affect any other rights held by authors or third parties in the article, including without limitation the rights of privacy and publicity. Use of the article must not assert or imply, whether implicitly or explicitly, any connection with, endorsement or sponsorship of such use by the author, publisher or any other party associated with the article.
For any reuse or distribution, users must include the copyright notice and make clear to others that the article is made available under a Creative Commons Attribution license, linking to the relevant Creative Commons web page. Users may impose no restrictions on the use of the article other than those imposed by the Creative Commons Attribution license.
To the fullest extent permitted by applicable law, the article is made available as is and without representation or warranties of any kind whether express, implied, statutory or otherwise and including, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of defects, accuracy, or the presence or absence of errors.
Main Article Content
The histostereological teratogenic effects of in-utero exposure to varied doses of lamotrigine on the developing fetal brain in albino rats (<i>Rattus Norvegicus</i>)
Abstract
The histoqualitative teratogenic effects of lamotrigine, a second-line anticonvulsant medicine, on the developing fetal brain structures when exposed in utero in a time- and dose-dependent manner remain unclear. On the other hand, lamotrigine is currently being widely prescribed as a first-line medicine in the management of maternal conditions like epileptic seizures and bipolar disorders, among others. The preferential use of lamotrigine is attributed to the considerations of its efficacy, tolerability, and minimal teratogenic effects on fetal organs like the brain, among others, though with insufficient supportive data. The aim of this study was therefore to evaluate the histo-quantitative effects of lamotrigine on the developing fetal brain structures when exposed in utero at varying dosages during different trimesters. The study adopted a post-test only experimental study design where a sample size of 30 sexually mature albino rat dams of the species (Rattus norvegicus) weighing between 250 + 30 grams was used. The rats were divided into two broad groups: 3 control rats and 27 dosage rats. The data collected was coded in Excel spreadsheets and analyzed in SPSS. Results were expressed as the mean + standard error of the mean (SEM), and values with a P < 0.05 were considered to be significant. Study findings depicted a reduction in brain weights, length, width, volumes, and volume densities of cortical and subcortical layers in a dose- and time-dependent manner. High lamotrigine dosages, especially during the first and second trimesters, were observed to be associated with significant mean reductions in the brain weights, length, width, volumes, and volume densities of the developing fetal brain structures. Therefore, further studies with higher primates closer to the human species as well as clinical trials are recommended to rule out the safety index of lamotrigine during pregnancy.
